Manasi Barath

Gilead Sciences (United States) — United States

Medicine · Health Sciences

8h-index191citations78works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(66), Cancer Immunotherapy and Biomarkers(60), Monoclonal and Polyclonal Antibodies Research(25), Brain Metastases and Treatment(7), Glioma Diagnosis and Treatment(5)

Publications78 total

Figure S8 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S7 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S13 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Data from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S8 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S2 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S9 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S5 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S6 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S19 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Table S3 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S12 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S18 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
Figure S10 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Bryan D. Lemon(43), Wade H. Aaron(43), Holger Wesche(43), Richard J. Austin(42), Timothy Z. Yu(42), Che‐Leung Law(39), Stephen Yu(39), Jessica O’Rear(39), Purbasa Patnaik(38), Sony Sotelo Rocha(38), Evan C. Callihan(38), Golzar Hemmati(38), Thomas Evans(36), Llewelyn Lao(35), Mabel C. Bush(35), Kevin Carlin(35), Michael Cremin(35), Avneel S. Hundal(35), Kathryn L. Strobel(34), Maria G. Guerrero(34)